{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-002876","form_type":"8-K","ticker":"AZTA","cik":"0000933974","company_name":"Azenta, Inc.","filed_at":"2026-02-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.081653+00:00","generated_at":"2026-05-16T05:12:19.510918+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Azenta Q1 revenue $149M flat; GAAP EPS -$0.11; non-GAAP EPS $0.09; reaffirms FY2026 guidance","bullets":["Revenue $149M (+1% YoY); organic revenue -1%. Sample Mgmt $81M flat; Multiomics $67M (+1%).","GAAP diluted EPS from continuing ops -$0.11 (vs -$0.16); total diluted EPS -$0.34. Non-GAAP EPS $0.09 (vs $0.12).","Gross margin 42.9% (down 380bps) on lost leverage & rework costs; operating margin -4.9%.","Adjusted EBITDA $13M, margin 8.5% (down 230bps). Board authorized $250M share repurchase program through Dec 2028.","Definitive agreement to sell B Medical Systems for $63M; close expected by March 31, 2026. FY2026 guidance reaffirmed: organic rev growth 3-5%, ~300bps adj EBITDA margin expansion."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-002876","json":"https://secwatch.observer/filing/0001437749-26-002876.json","markdown":"https://secwatch.observer/filing/0001437749-26-002876.md","text":"https://secwatch.observer/filing/0001437749-26-002876.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/933974/000143774926002876/0001437749-26-002876-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/933974/000143774926002876/azta20251120_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T05:12:19.510918+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}